Joseph Patrick Cooper - 29 May 2025 Form 4 Insider Report for Quoin Pharmaceuticals, Ltd. (QNRX)

Role: Director
Signature: /s/ Joseph Cooper
Issuer symbol: QNRX
Transactions as of: 29 May 2025
Net transactions value: $0
Form type: 4
Filing time: 02 Jun 2025, 20:37:15 UTC
Previous filing: 10 Dec 2024
Next filing: 06 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Cooper Joseph Patrick	Director	C/O QUOIN PHARMACEUTICALS LTD.,, 42127 PLEASANT FOREST COURT, ASHBURN	/s/ Joseph Cooper	02 Jun 2025	0001368711

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	QNRX	Share Option (Right to Buy)	Award	$0	+7,760		$0.000000	7,760	29 May 2025	ADS	7,760	$9.07	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares ("ADSs"). Each ADS represents thirty-five ordinary shares of the Issuer.
F2	The option vests in four annual installments with 20% vesting on each of May 29, 2026, 2027 and 2028 and 40% vesting on May 29, 2029.